MPLT vs SHW · $1.24B cap vs P/E 29, rev $12.46B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
MPLT does not have a complete income-statement cache yet.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
MPLT currently screens at market cap $1.24B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the MPLT and SHW stock pages for the full models.
Not investment advice.